PCSK9 monoclonal antibody

PCSK9 inhibitor (monoclonal antibody) · Amgen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PCSK9 monoclonal antibody, covering 2015-10-01 to 2016-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody [Phase 3]